Late Breaking Clinical Research Session recordings now available.

Late Breaking Clinical Research Session I

The HFSA ASM Late Breaking Clinical Research Session I was livestreamed on Sunday, September 29. Details on the session and a link to the session recording are available below. 

This session included the following trials and research:

  • Efficacy Of Semaglutide In Patients With Obesity And HFpEF According To Frailty Status: A Pooled Analysis From The STEP-HFpEF Program
  • Effects Of Semaglutide In Patients With Obesity-related Heart Failure With Preserved Ejection Fraction According To The Exercise Function At Baseline: Insights From The STEP-HFpEF Program
     
  • Efficacy And Safety Of Finerenone In Patients With Heart Failure And Mildly Reduced Or Preserved Ejection Fraction And A Recent Worsening Heart Failure Event: The FINEARTS-HF Trial
     
  • Efficacy And Safety Of Finerenone Across The Ejection Fraction Spectrum In Heart Failure With Mildly Reduced And Preserved Ejection Fraction: The FINEARTS-HF Trial
     
  • Exploratory Biomarker Analyses From HELIOS-B, A Phase 3 Study of Vutrisiran In Patients with Transthyretin Amyloidosis with Cardiomyopathy
  • Effects of Vutrisiran on Echocardiographic Cardiac Structure and Function: The HELIOS-B Trial

 

Back to the main Late Breaking Clinical Research page >>